Home

WPI

Par Pharmaceuticals - Buried in the Generic Drugs Battlefield

By MagicDiligence on Thu, 2011-05-12 08:49
(via www.magicdiligence.com)

Par Pharmaceuticals is one of the smaller soldiers in the highly competitive generic drugs industry. Despite an excellent industry outlook, it will be an uphill battle for Par to generate outsized economic returns.

Advertisement:

Magic Formula Stock Review: Endo Pharmaceuticals (ENDP)

By MagicDiligence on Wed, 2010-04-21 08:38
(via www.magicdiligence.com)

Endo Pharmaceuticals is a highly profitable specialty drug maker specializing in pain killers such as Lidoderm, Opana, and Percocet. While the outlook is very good for the next few years, major patent cliffs and pipeline problems could keep the valuation lower than normal.